06826.HK
Shanghai Haohai Biological Technology Co., Ltd.
HKSE · Healthcare · Biotechnology · CN
HKD 15.63
−2.68%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 6.80x
- P/E 2027E
- 6.12x
- P/E 2028E
- 5.70x
- P/S forward
- 2.07x
Trailing multiples
Trailing twelve months
- P/E TTM
- 30.21x
- PEG TTM
- 24.70x
- Price / book
- 0.57x
- Price / sales
- 1.32x
- Price / cash flow
- 6.30x
Enterprise value
- Enterprise value
- HKD 1.5B
- EV / sales
- 0.56x
- EV / EBITDA
- 10.48x
- EV / EBIT
- -26.97x
- Market cap
- HKD 3.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026